Get the Stockscreener App
2.69
1.10%
-0.03
After Hours:
2.69
Harvard Bioscience Inc stock is traded at $2.69, with a volume of 126.65K.
It is down -1.10% in the last 24 hours and down -6.60% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
See More
Previous Close:
$2.72
Open:
$2.72
24h Volume:
126.65K
Relative Volume:
1.03
Market Cap:
$116.39M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-20.69
EPS:
-0.13
Net Cash Flow:
$10.81M
1W Performance:
+1.89%
1M Performance:
-6.60%
6M Performance:
-36.56%
1Y Performance:
-37.44%
1-Day Range:
$2.65
$2.73
1-Week Range:
$2.60
$2.73
52-Week Range:
$2.50
$5.56
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
The past three years for Harvard Bioscience (NASDAQ:HBIO) investors has not been profitable - Yahoo Finance
ACAD: 3 Healthcare Stocks Analysts Expect to Rally Over 50% - StockNews.com
Artificially Intelligent Stethoscope Market Current Scenario and Future Prospects|Eko Devices, Littmann Stethoscopes - Daily Invest News
272 Capital LP Has $4.38 Million Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Laboratory Colorimeter Market By Sources Analysis, Share, Trends, Size, Forecast From (2024-2034) - Third Eye News
Laboratory Colorimeter Market By Sources Analysis, Share, Trends, Size, Forecast From (2024-2034) - United States Security Bayonet ...
Immunohematology Market Growth Revenue, Industry Demand Report To 2033 - WhaTech
Global Perfusion Systems Market Innovations Investigated by Trends and Outlook 2024 - WhaTech
FLO stock rated an Underperform by Exane BNP Paribas - Knox Daily
Harvard’s latest medical innovation advances 3D printed blood vessels - 3D Printing Industry
Laboratory Colorimeter Market By Sources Analysis, Share, Trends, Size, Forecast From (2024-2034) - KnowCasino
Long Term Trading Analysis for (THRD) - Stock Traders Daily
Harvard Bioscience stock hits 52-week low at $2.6 - Investing.com
United States Turbidity Instruments Market Size, Share, Trends, Growth, Analysis & Forecast - Third Eye News
Electroporator Industry – Market Insights and Growth Potential - Elektrotransports.lv
United States UV Spectrophotometer Market Size, Share, Trends, Growth, Analysis & Forecast - Third Eye News
Harvard’s Wyss Creates New Way to 3D Print Blood Vessels—Moves Closer to Artificial Organs - 3DPrint.com
Harvard Bioscience to showcase solutions for preclinical, organoid applications - TipRanks
Harvard Bioscience to Showcase Latest Solutions for - GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting - Marketscreener.com
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting - StockTitan
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development - Benzinga
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology - Financial Times
Sidoti Events, LLC's Virtual September Small-Cap Conference - Via Ritzau
Life Science And Chemical Instrumentation Market Size, Share, Trends, Demand, Forecast To 2033 - WhaTech Technology and Markets News
Electroporation Technology Market is thriving worldwide by 2031 - Elektrotransports.lv
United States Telemetry Implant Market By Application - Third Eye News
Acadian Asset Management LLC Buys 41,520 Shares of Woori Financial Group Inc. (NYSE:WF) - Defense World
Private Advisor Group LLC Purchases 14,574 Shares of Invesco S&P 500 Momentum ETF (NYSEARCA:SPMO) - Defense World
Xinyi Glass Holdings Limited (OTCMKTS:XYIGF) Short Interest Down 33.0% in August - Defense World
Zacks Research Analysts Lower Earnings Estimates for Grocery Outlet Holding Corp. (NASDAQ:GO) - Defense World
Marathon Gold (OTCMKTS:MGDPF) Shares Up 2.4% - Defense World
Short Interest in Zhejiang Expressway Co., Ltd. (OTCMKTS:ZHEXF) Grows By 32.8% - Defense World
Trustpilot Group plc (LON:TRST) Insider Hanno Damm Sells 214,856 Shares of Stock - Defense World
Acadian Asset Management LLC Acquires 860,854 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World
Acadian Asset Management LLC Has $3.02 Million Holdings in Seer, Inc. (NASDAQ:SEER) - Defense World
Japan Petroleum Exploration Stock to Split on Monday, September 30th (OTC:JPTXF) - Defense World
Invesco DB Base Metals Fund (NYSEARCA:DBB) Trading 1.1% Higher - Defense World
Short Interest in ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS) Declines By 42.7% - Defense World
Matrix Service Forecasted to Earn Q1 2025 Earnings of ($0.18) Per Share (NASDAQ:MTRX) - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Recommendation of “Buy” by Analysts - Defense World
Q3 2024 EPS Estimates for SoFi Technologies, Inc. Increased by Analyst (NASDAQ:SOFI) - Defense World
Home Healthcare Equipment Market Share and Outlook 2024 In Latest Study - WhaTech
Electrophoresis Market Size, Share, Trends, Revenue Growth And Outlook By 2033 - WhaTech
Harvard Bioscience Inc. [HBIO] Investment Appeal on the Rise - Knox Daily
Wells Fargo’s latest rating for EFX stock - Knox Daily
Perfusion Systems Market Boosting the Growth Worldwide during 2024-2032 - Talented India
HC Bioscience Appoints Simon Tsang, Ph.D. as Chief Business Officer to Lead Business Development - Business Wire
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference - Yahoo Finance UK
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference - Marketscreener.com
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference - GlobeNewswire
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):